Quarterly Call Option Transactions in Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX) during . The information is specifically focused on institutions that hold call options of Lineage Cell Therapeutics, Inc..
Calls Purchased
Calls Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 278,000 | 0 | 278,000 | 40,200 | 0 | 40,200 | 237,800 | |
Q4 2021 | 28,800 | 44,900 | 73,700 | 57,700 | 0 | 57,700 | 16,000 | |
Q1 2022 | — | 203,600 | 56,500 | 260,100 | -260,100 | |||
Q2 2022 | 11,400 | 0 | 11,400 | — | 11,400 | |||
Q3 2022 | — | 80,500 | 0 | 80,500 | -80,500 | |||
Q4 2022 | 0 | 16,500 | 16,500 | — | 16,500 | |||
Q1 2023 | 6,800 | 24,200 | 31,000 | — | 31,000 | |||
Q2 2023 | — | 18,200 | 0 | 18,200 | -18,200 | |||
Q3 2023 | 10,700 | 14,500 | 25,200 | — | 25,200 | |||
Q4 2023 | — | 12,500 | 0 | 12,500 | -12,500 | |||
Q1 2024 | 18,100 | 0 | 18,100 | — | 18,100 | |||
Q2 2024 | 9,900 | 0 | 9,900 | — | 9,900 | |||
Q3 2024 | 32,500 | 0 | 32,500 | — | 32,500 |